Healthcare provider profile · identity verified

Maira Ilahi, DO

Family Practice · NIAGARA FALLS, NY · NPI 1548828015

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	948	57
Atorvastatin Calcium	Atorvastatin Calcium	583	47
Eliquis	Apixaban	583	31
Amlodipine Besylate	Amlodipine Besylate	429	46
Pantoprazole Sodium	Pantoprazole Sodium	395	32
Metoprolol Succinate	Metoprolol Succinate	387	38
Potassium Chloride	Potassium Chloride	387	24
Furosemide	Furosemide	342	35
Memantine Hcl	Memantine Hcl	338	13
Levetiracetam	Levetiracetam	223	21
Escitalopram Oxalate	Escitalopram Oxalate	222	15
Donepezil Hcl	Donepezil Hcl	206	14
Sertraline Hcl	Sertraline Hcl	182	12
Lisinopril	Lisinopril	180	25
Spironolactone	Spironolactone	176	11
Metoprolol Tartrate	Metoprolol Tartrate	163	14
Duloxetine Hcl	Duloxetine Hcl	153	16
Losartan Potassium	Losartan Potassium	152	12
Gabapentin	Gabapentin	147	26
Myrbetriq	Mirabegron	145	suppressed
Divalproex Sodium	Divalproex Sodium	144	suppressed
Clopidogrel	Clopidogrel Bisulfate	143	14
Citalopram Hbr	Citalopram Hydrobromide	135	suppressed
Famotidine	Famotidine	130	11
Hydrochlorothiazide	Hydrochlorothiazide	124	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	122	16
Jardiance	Empagliflozin	107	suppressed
Omeprazole	Omeprazole	104	suppressed
Bumetanide	Bumetanide	100	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	100	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	97	15
Trazodone Hcl	Trazodone Hcl	97	suppressed
Metformin Hcl	Metformin Hcl	96	12
Allopurinol	Allopurinol	93	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	31
Carvedilol	Carvedilol	86	suppressed
Gemtesa	Vibegron	85	suppressed
Metformin Hcl Er	Metformin Hcl	80	11
Mirtazapine	Mirtazapine	78	18
Baclofen	Baclofen	72	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	70	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	67	suppressed
Finasteride	Finasteride	67	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	67	suppressed
Pravastatin Sodium	Pravastatin Sodium	67	suppressed
Lamotrigine	Lamotrigine	64	suppressed
Valsartan	Valsartan	57	suppressed
Risperidone	Risperidone	56	suppressed
Benazepril Hcl	Benazepril Hcl	55	suppressed
Trospium Chloride	Trospium Chloride	55	suppressed
Montelukast Sodium	Montelukast Sodium	54	suppressed
Desloratadine	Desloratadine	52	suppressed
Entresto	Sacubitril/Valsartan	49	suppressed
Topiramate	Topiramate	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	45	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Buspirone Hcl	Buspirone Hcl	43	suppressed
Oxycodone Hcl	Oxycodone Hcl	42	14
Simvastatin	Simvastatin	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Xarelto	Rivaroxaban	42	suppressed
Digoxin	Digoxin	40	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	40	15
Cephalexin	Cephalexin	38	18
Lovastatin	Lovastatin	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	38	suppressed
Torsemide	Torsemide	38	suppressed
Gemfibrozil	Gemfibrozil	37	suppressed
Memantine Hcl Er	Memantine Hcl	36	suppressed
Ursodiol	Ursodiol	36	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	34	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Labetalol Hcl	Labetalol Hcl	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Prednisone	Prednisone	33	16
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Atenolol	Atenolol	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	13
Tolterodine Tartrate Er	Tolterodine Tartrate	31	suppressed
Nystatin	Nystatin	30	16
Solifenacin Succinate	Solifenacin Succinate	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	19
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Lorazepam	Lorazepam	25	13
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	suppressed
Budesonide Ec	Budesonide	21	suppressed
Carbamazepine	Carbamazepine	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	13
Ozempic	Semaglutide	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Rivastigmine	Rivastigmine Tartrate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Lidocaine Hcl	Lidocaine Hcl	15	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nitroglycerin Patch	Nitroglycerin	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error